Free Trial

Yield10 Bioscience Q1 2024 Earnings Report

Yield10 Bioscience logo
$0.02 0.00 (0.00%)
As of 02/20/2025

Yield10 Bioscience EPS Results

Actual EPS
-$4.77
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Yield10 Bioscience Revenue Results

Actual Revenue
$0.30 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Yield10 Bioscience Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Yield10 Bioscience Earnings Headlines

$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.
See More Yield10 Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Yield10 Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Yield10 Bioscience and other key companies, straight to your email.

About Yield10 Bioscience

Yield10 Bioscience (NASDAQ:YTEN) operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

View Yield10 Bioscience Profile

More Earnings Resources from MarketBeat